4.7 Article

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy

期刊

LEUKEMIA
卷 29, 期 10, 页码 2033-2038

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2015.118

关键词

-

资金

  1. National Center for Advancing Translational Sciences, a component of the National Institutes of Health (NIH) [UL1 TR000135]
  2. Gene and Mary-Lou Kurtz fellowship in myeloma
  3. Mayo Clinic Hematological Malignancies Program [R01 CA168762-03, R01CA 107476-11, R01CA 167511-2]

向作者/读者索取更多资源

Normalization of the serum-free light-chain ratio (FLCr) with the absence of bone marrow monoclonal plasma cells following achievement of a complete response (CR) to therapy denotes a stringent CR in multiple myeloma (MM), and is associated with improved overall survival (OS). However, its value in patients achieving

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据